During the November Hockey Fights Cancer (HFC) campaign presented by Kaiser Permanente, the Sharks Foundation focused their ...

According to the Global Cancer Observatory, ovarian cancer was the third most common cancer among women in India in 2022, ...

The hearse carrying Janey Godley has made its way through Edinburgh as the Scottish comedian's "final tour" takes place. The ...

In the cancer world — or anywhere — the ability to give thanks in the midst of trials is an acquired skill. It must be ...

The European Commission has approved mirvetuximab soravtansine for select patients with pretreated folate receptor–alpha (FRα)-positive, platinum-resistant ovarian cancer.

A group of ovarian cancer survivors call themselves the Fun Posse. “It’s kind of an exclusive club. But it’s not a club you ...

Verastem's promising progress in RAS-driven cancers, potential FDA approval, and growth opportunities present a bullish ...

A new gold-based drug can slow tumour growth in animals by 82% and target cancers more selectively than standard chemotherapy ...

When it comes to ovarian cancer, early detection plays a crucial role in improving survival rates. Catching the disease in ...

Corcept Therapeutics specializes in cortisol-modulating drugs. Click here to read why CORT stock offers investment potential.

Calibration and decision curve analyses confirmed the model’s reliability and clinical usefulness. “Clinicians can input ...

Mayo Clinic Comprehensive Cancer Center experts highlight breast cancer research that may reduce or eliminate the need for chemotherapy and endocrine treatments and may allow for shorter and less ...